ARMORUM LIMITED
Executive Summary
Armorum Limited’s most recent financial data indicates a concerning deterioration in net assets, moving to a slight net liability position despite apparently strong current asset coverage. Large deferred income liabilities and director loans, coupled with dividend payments in a negative equity context, raise solvency and liquidity concerns. While statutory compliance is maintained, further investigation into cash flow dynamics and governance practices is warranted to fully assess financial stability and operational sustainability.
View Full Analysis Report →- Legal registered address
- Third Floor 1 New Fetter Lane London United Kingdom EC4A 1AN Copied!
Latest financial results as of 31 August 2025- Current assets
- £303.19k
- Fixed assets
- £1.00k
- Current creditors
- £100.04k
- Shareholders funds
- £-22
View full financial accounts- Current assets
- £303.19k
- Fixed assets
- £1.00k
- Current creditors
- £100.04k
- Shareholders funds
- £-22
- Company number
- 13830123 Copied!
Accounts
Latest annual accounts were to 31 March 2024
Next annual accounts are due by 31 December 2025
Company financial year end is on 31 March 2026
Confirmation statement
Latest confirmation statement statement dated 4 January 2025
Next statement due by 18 January 2026
Nature of business (SIC)
62020 - Information technology consultancy activities
Latest company documents
Date | Description |
---|---|
17/03/2517 March 2025 | Amended micro company accounts made up to 2024-03-31 |
06/01/256 January 2025 | Confirmation statement made on 2025-01-04 with no updates |
01/11/241 November 2024 | Micro company accounts made up to 2024-03-31 |
31/03/2431 March 2024 | Annual accounts for year ending 31 Mar 2024 |
12/01/2412 January 2024 | Confirmation statement made on 2024-01-04 with no updates |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company